Smarter stem cells: how AI is supercharging iPSC technology.

Integrated with artificial intelligence (AI), induced pluripotent stem cell (iPSC) technology could enhance disease modeling, cellular biology, regenerative medicine, and pharmaceutical development. AI has enhanced iPSC differentiation, cultural conditions, and speed of disease-specific model development. Furthermore, AI-based massive omics database analysis exposes hidden biological tendencies, enhancing customized treatment. Investigating new AI algorithms will enable one to solve problems, including interpretability and data quality, resulting from AI's interaction with iPSC technology. These advances fundamentally alter stem cell research and therapeutic applications, therefore facilitating the emergence of regenerative medicine and precision healthcare. AI has evolved in biomedical research into a transformational technology unique in great data analysis, predictive modeling, and automation capacity. AI integration increases the development of patient-specific cell types for disease modeling, pharmacological research, and regenerative medicine by substantially improving IPSC-based technologies. Emphasizing changes in disease models, alternative methodologies, and cellular reprogramming, this work examines current advancements in the use of AI in iPSC technology. The argument on significant obstacles and possibilities reveals how AI could alter the objectives of iPSC research and implementation.